BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26110312)

  • 1. SYNGAP1 Mutation in Focal and Generalized Epilepsy: A Literature Overview and A Case Report with Special Aspects of the EEG.
    von Stülpnagel C; Funke C; Haberl C; Hörtnagel K; Jüngling J; Weber YG; Staudt M; Kluger G
    Neuropediatrics; 2015 Aug; 46(4):287-91. PubMed ID: 26110312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chewing induced reflex seizures ("eating epilepsy") and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases.
    von Stülpnagel C; Hartlieb T; Borggräfe I; Coppola A; Gennaro E; Eschermann K; Kiwull L; Kluger F; Krois I; Møller RS; Rössler F; Santulli L; Schwermer C; Wallacher-Scholz B; Zara F; Wolf P; Kluger G
    Seizure; 2019 Feb; 65():131-137. PubMed ID: 30685520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
    Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
    BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
    Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
    Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.
    Okazaki T; Saito Y; Hiraiwa R; Saitoh S; Kai M; Adachi K; Nishimura Y; Nanba E; Maegaki Y
    Epileptic Disord; 2017 Sep; 19(3):339-344. PubMed ID: 28721930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
    Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
    J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA).
    Klitten LL; Møller RS; Nikanorova M; Silahtaroglu A; Hjalgrim H; Tommerup N
    Epilepsia; 2011 Dec; 52(12):e190-3. PubMed ID: 22050443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
    Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
    Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.
    Agarwal M; Johnston MV; Stafstrom CE
    Int J Dev Neurosci; 2019 Nov; 78():65-76. PubMed ID: 31454529
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Vlaskamp DRM; Shaw BJ; Burgess R; Mei D; Montomoli M; Xie H; Myers CT; Bennett MF; XiangWei W; Williams D; Maas SM; Brooks AS; Mancini GMS; van de Laar IMBH; van Hagen JM; Ware TL; Webster RI; Malone S; Berkovic SF; Kalnins RM; Sicca F; Korenke GC; van Ravenswaaij-Arts CMA; Hildebrand MS; Mefford HC; Jiang Y; Guerrini R; Scheffer IE
    Neurology; 2019 Jan; 92(2):e96-e107. PubMed ID: 30541864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYNGAP1-DEE: A visual sensitive epilepsy.
    Lo Barco T; Kaminska A; Solazzi R; Cancés C; Barcia G; Chemaly N; Fontana E; Desguerre I; Canafoglia L; Hachon Le Camus C; Losito E; Villard L; Eisermann M; Dalla Bernardina B; Villeneuve N; Nabbout R
    Clin Neurophysiol; 2021 Apr; 132(4):841-850. PubMed ID: 33639450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
    Verma V; Mandora A; Botre A; Clement JP
    Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic generalized epilepsies imitating focal epilepsies.
    Ferrie CD
    Epilepsia; 2005; 46 Suppl 9():91-5. PubMed ID: 16302881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and gene analysis of SYNGAP1-related epilepsy in children].
    Tian XJ; Fang F; Ding CH; Ren XT; Wang X; Wang XF; Lyu JL; Jin H; Han TL; Deng J
    Zhonghua Er Ke Za Zhi; 2021 Dec; 59(12):1059-1064. PubMed ID: 34856666
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.
    Wiltrout K; Brimble E; Poduri A
    Epilepsia; 2024 May; 65(5):1428-1438. PubMed ID: 38470175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.
    Hamdan FF; Daoud H; Piton A; Gauthier J; Dobrzeniecka S; Krebs MO; Joober R; Lacaille JC; Nadeau A; Milunsky JM; Wang Z; Carmant L; Mottron L; Beauchamp MH; Rouleau GA; Michaud JL
    Biol Psychiatry; 2011 May; 69(9):898-901. PubMed ID: 21237447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the misdiagnosis of generalized epilepsy as partial epilepsy: causes and consequences.
    Benbadis SR
    Seizure; 1999 May; 8(3):140-5. PubMed ID: 10356369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the phenotypic spectrum of SLC6A1 mutations.
    Johannesen KM; Gardella E; Linnankivi T; Courage C; de Saint Martin A; Lehesjoki AE; Mignot C; Afenjar A; Lesca G; Abi-Warde MT; Chelly J; Piton A; Merritt JL; Rodan LH; Tan WH; Bird LM; Nespeca M; Gleeson JG; Yoo Y; Choi M; Chae JH; Czapansky-Beilman D; Reichert SC; Pendziwiat M; Verhoeven JS; Schelhaas HJ; Devinsky O; Christensen J; Specchio N; Trivisano M; Weber YG; Nava C; Keren B; Doummar D; Schaefer E; Hopkins S; Dubbs H; Shaw JE; Pisani L; Myers CT; Tang S; Tang S; Pal DK; Millichap JJ; Carvill GL; Helbig KL; Mecarelli O; Striano P; Helbig I; Rubboli G; Mefford HC; Møller RS
    Epilepsia; 2018 Feb; 59(2):389-402. PubMed ID: 29315614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GEFS+ where focal seizures evolve from generalized spike wave: video-EEG study of two children.
    Deng YH; Berkovic SF; Scheffer IE
    Epileptic Disord; 2007 Sep; 9(3):307-14. PubMed ID: 17884755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.
    Writzl K; Knegt AC
    Am J Med Genet A; 2013 Jul; 161A(7):1682-5. PubMed ID: 23687080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.